Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation

By Carter Laura   Carreno Beatriz  

Immunologic Research, Vol. 28, Iss. 1, 2003-08 ,pp. : 49-59

Humana Press, Inc

Access to resources Recommend Favorite

Primary T-Lymphocyte Immunodeficiencies

By Fischer A.  

Clinical Reviews in Allergy and Immunology, Vol. 20, Iss. 1, 2001-02 ,pp. : 3-24

Humana Press, Inc

Access to resources Recommend Favorite

Extrathymic T-lymphocyte development

By Blais M.-E.   Louis I.   Corneau S.   Gerard G.   Terra R.   Perreault C.  

Experimental Hematology, Vol. 31, Iss. 5, 2003-05 ,pp. : 349-354

Elsevier

Access to resources Recommend Favorite

Primary T-lymphocyte immunodeficiencies

By Fischer Alain  

Clinical Reviews in Allergy and Immunology, Vol. 20, Iss. 1, 2001-02 ,pp. : 3-26

Humana Press, Inc

Access to resources Recommend Favorite

Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection

By Warger Tobias  

Clinical Reviews in Allergy and Immunology, Vol. 32, Iss. 1, 2007-02 ,pp. : 57-65

Humana Press, Inc

Access to resources Recommend Favorite